Citrix Systems Inc (CTXS) 86.98 $CTXS Global Workspace

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Citrix Systems Inc (CTXS) 86.98 $CTXS

Global Workspace Delivery Network Market Growth of 18.42% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Citrix Systems, Cisco, CloudGenix - Research and Markets
BusinessWire - Fri Sep 02, 7:04AM CDT
Research and Markets has announced the addition of the "Global Workspace Delivery Network Market 2016-2020" report to their offering.
CTXS: 86.98 (-0.30)

Hokuhoku Financial Group, Inc. Adopts Citrix XenDesktop for Next Generation Desktop and Application Infrastructure
BusinessWire - Thu Sep 01, 7:00AM CDT
Citrix today announced that Japanese regional bank Hokuhoku Financial Group, Inc. (Hokuhoku FG) will be deploying Citrix XenDesktop for its next generation virtual desktop and application infrastructure integration in the first half of 2017. Based on a competitive review, Hokuhoku FG selected XenDesktop for its superior performance, seamless user experience and enhanced security, as well as for the company's proven track record with server-based computing (SBC) secure app delivery solutions.
CTXS: 86.98 (-0.30)

Citrix Executives to Present at Upcoming Investor Conferences
BusinessWire - Wed Aug 31, 4:43PM CDT
Citrix Systems, Inc. (NASDAQ:CTXS) today announced that executives will attend two upcoming investor conferences.
CTXS: 86.98 (-0.30)

CORRECTING and REPLACING Citrix Named A Leader in Gartner Magic Quadrant for Application Delivery Controllers for Tenth Consecutive Year
BusinessWire - Wed Aug 31, 3:28PM CDT
Fourth paragraph of release should read: The full 2016 Gartner Magic Quadrant... (instead of The full 2015 Gartner Magic Quadrant...).
CTXS: 86.98 (-0.30)

Citrix Named A Leader in Gartner Magic Quadrant for Application Delivery Controllers for Tenth Consecutive Year
BusinessWire - Wed Aug 31, 1:42PM CDT
Citrix, a leading provider of the Citrix NetScaler application delivery controller (ADC) solution, today announced that it has been positioned by Gartner, Inc. in the Leaders quadrant of the 2016 Magic Quadrant for Application Deliver Controllers. [1] NetScaler is the market-leading ADC that powers application delivery infrastructure for some of the world's largest enterprises, cloud hosting providers and Telcos. (ADC) report authored by Gartner analysts Mark Fabbi and Andrew Lerner for the tenth consecutive year.
IT: 91.43 (+0.64), CTXS: 86.98 (-0.30)

Citrix (CTXS) Brings NetScaler CPX's Free Developer Version
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 8:11AM CDT
Citrix Systems, Inc. (CTXS) recently announced the release of NetScaler CPX Express to cater to the high demand for application development.
AVID: 9.12 (+0.08), AZPN: 45.92 (+0.30), CALD: 19.93 (+0.72), CTXS: 86.98 (-0.30)

Citrix Releases Free Developer Version of NetScaler Load Balancer for Microservices App Developers
BusinessWire - Wed Aug 24, 7:00AM CDT
Digital business transformation is driving line of business (LOB) to adopt rapid application development and deployment methodologies, such as DevOps. To stay ahead of the competition and adapt to rapidly changing customer and market demands, businesses and governments must automate and continuously adjust key processes. To do so, companies are increasingly developing their own applications to improve internal productivity and enhance customer engagement. Today, Citrix announced NetScaler CPX Express, a free developer version of NetScaler CPX, which is a NetScaler in a container form factor that delivers a battle-tested load balancer for developers to create microservices applications.
CTXS: 86.98 (-0.30)

After Yesterday's Rally of 1.40% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Aug 11, 1:15PM CDT
Citrix Systems (NASDAQ:CTXS) traded in a range yesterday that spanned from a low of $85.04 to a high of $86.84. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $85.70 on volume of 635,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTXS: 86.98 (-0.30)

Citrix Systems Set to Possibly Pullback After Yesterday's Rally of 1.40%
Comtex SmarTrend(R) - Thu Aug 11, 1:14PM CDT
Citrix Systems (NASDAQ:CTXS) traded in a range yesterday that spanned from a low of $85.04 to a high of $86.84. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $85.70 on volume of 635,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CTXS: 86.98 (-0.30)

Tech Stocks Technical Report -- Citrix Systems, NetSuite, NetScout Systems, and Ellie Mae
PR Newswire - Thu Aug 11, 7:53AM CDT
The Technology sector's estimated earnings growth for the third quarter has been impressive so far, up 3.1% from 2.4% from July 01, 2016 to August 05, 2016. Stock-Callers.com reviews the following equities and see which direction they could be headed next: Citrix Systems Inc. (NASDAQ: CTXS), NetSuite Inc. (NYSE: N), NetScout Systems Inc. (NASDAQ: NTCT), and Ellie Mae Inc. (NYSE: ELLI). Today's research reports on the aforementioned stocks are downloadable for free upon registration at:
ELLI: 98.80 (-0.58), NTCT: 30.11 (+0.38), N: 108.96 (-0.05), CTXS: 86.98 (-0.30)

Zacks.com featured highlights: Macy's, General Mills, Zoetis, Boston Scientific and Citrix Systems
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:30AM CDT
Zacks.com featured highlights: Macy's, General Mills, Zoetis, Boston Scientific and Citrix Systems
BSX: 24.26 (-0.07), ZTS: 51.26 (+0.15), M: 36.64 (+0.30), GIS: 70.94 (+0.83), CTXS: 86.98 (-0.30)

Montefiore Health System Realizes $5 Million in Savings with Citrix
BusinessWire - Thu Aug 04, 4:00AM CDT
The transformation to value-based healthcare, which demands a move away from a supply-driven health care system that is organized around fees, toward a patient-centered system, organized around what patients need. The move is well underway and organizations are making large-scale changes to deliver on the efficiencies it promises. Moving to electronic-based medical records per the Electronic Medical Record (EMR) mandates put in place by the U.S. federal government is part of the equation as it adds the technologies that ultimately enable clinicians to be more efficient, allowing for more one-on-one time with patients and less time spent on documentation. Montefiore Health System (MHS), a premier academic medical center, and the University Hospital for Albert Einstein College of Medicine adopted Citrix virtualization technology to adapt to this changing trend and comply with EMR mandates. MHS grew significantly over the course of three years, increasing its user base from 18,000 to a staggering 28,000 workers, which includes ten hospitals, an extended-care facility with 150 locations in New York state, the largest school health program and a home-health program. As a result of this quick growth, the IT organization at MHS needed solutions that would give clinicians seamless access to the large number of patient medical records without impacting their growing care team's ability to provide quality patient care. By using low-cost devices such as thin clients and keeping the complex configuration needs of different clinical applications contained within the data center, MHS has realized more than $5 million in hardware savings.
CTXS: 86.98 (-0.30)

5 Top ROE Stocks to Buy as Earnings Growth Remains Elusive
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 7:57AM CDT
A high ROE ensures that the company is reinvesting its cash at a high rate of return.
ZTS: 51.26 (+0.15), BSX: 24.26 (-0.07), M: 36.64 (+0.30), GIS: 70.94 (+0.83), CTXS: 86.98 (-0.30)

Look for Shares of Citrix Systems to Potentially Rebound after Yesterday's 2.81% Sell Off
Comtex SmarTrend(R) - Tue Aug 02, 3:22PM CDT
Citrix Systems (NASDAQ:CTXS) traded in a range yesterday that spanned from a low of $83.93 to a high of $86.20. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $86.47 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CTXS: 86.98 (-0.30)

Watch for Citrix Systems to Potentially Rebound After Falling 2.81% Yesterday
Comtex SmarTrend(R) - Tue Aug 02, 3:20PM CDT
Citrix Systems (NASDAQ:CTXS) traded in a range yesterday that spanned from a low of $83.93 to a high of $86.20. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $86.47 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CTXS: 86.98 (-0.30)

Harris (HRS) Tops Earnings, Lags Revenue Estimates in Q4
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:47AM CDT
Harris (HRS) reported better-than-expected earnings in the quarter.
HRS: 93.69 (+0.84), PLXS: 46.85 (+0.41), INTC: 36.08 (+0.06), CTXS: 86.98 (-0.30)

Citrix Signs Global Partner Agreement with Cloud DC
BusinessWire - Tue Aug 02, 5:00AM CDT
Cloud DC Inc. has just executed a global CSP Distribution agreement with Citrix.
CTXS: 86.98 (-0.30)

Downgrade Alert for Citrix Systems (CTXS)
Comtex SmarTrend(R) - Tue Aug 02, 3:34AM CDT
Citrix Systems (NASDAQ:CTXS) was downgraded from Hold to Underperform at Jefferies today. The stock closed yesterday at $86.62 on volume of 3.1 million shares, above average daily volume of 1.6 million. Over the past year, Citrix Systems has traded in a range of $60.91 to $90.00 and closed yesterday at $86.62, 42% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 1.2%.
CTXS: 86.98 (-0.30)

Next Support Level for Citrix Systems (CTXS) is $87.64
Comtex SmarTrend(R) - Mon Aug 01, 8:54AM CDT
Shares of Citrix Systems (NASDAQ:CTXS) have bearishly opened below the pivot of $88.80 today and have reached the first support level of $88.38. Should the shares continue to fall, the support pivots of $87.64 and $86.48 will be of interest.
CTXS: 86.98 (-0.30)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing Insights: Man Group PLC's Position in Spectris plc

Updated Category News Views 315

Understanding Man Group PLC's Investment Position Man Group PLC, a primary player in investment management, recently announced its public interests regarding relevant securities in Spectris plc. This disclosure highlights its strategic investment and positions in the market. Key Information Disclosure As per regulatory requirements, Man Group PLC has provided essential...

Continue Reading
Coca Cola Surpasses Expectations Amidst Market Challenges

Updated Category News Views 357

Coca Cola Surpasses Expectations Amidst Market Challenges On a recent earnings announcement, The Coca Cola Company (NYSE: KO) exceeded Wall Street predictions, showcasing a resilient strategy to enhance revenue and earnings despite shifting consumer preferences. While demand for beverages has softened, Coca Cola's ability to raise prices proved beneficial, even as...

Continue Reading
Joget Enhances Application Development Using AI and Security

Updated Category News Views 86

Transforming Application Development with Joget AI The innovative Vibe Composition approach by Joget empowers enterprises to craft robust applications by utilizing trusted, composable components rather than traditional raw coding methods. This modern take on application development is encapsulated within the Joget AI Designer, making the process both efficient and secure....

Continue Reading
Gimme Credit Unveils Innovative Platform to Enhance Global Research

Updated Category News Views 215

Introducing Gimme Credit's New Client Platform Gimme Credit, a prominent independent provider of credit research and data, has recently launched a cutting-edge delivery platform. This initiative marks a significant step in the company's global expansion and innovation efforts. An Era of Growth and Technological Innovation The new platform utilizes a cloud-based...

Continue Reading
Comprehensive Overview of SCOR's Share and Voting Rights Data

Updated Category News Views 36

Understanding SCOR's Share Capital and Voting Rights In today's competitive landscape, it is crucial for companies to maintain transparency regarding their operations and shareholder information. SCOR, a notable player in the global reinsurance market, has recently provided an insightful declaration concerning its share capital and voting rights. This information...

Continue Reading